Kancera AB (publ) announced that Peter Selin is appointed as new Chief Executive Officer (CEO) as of July 1 2023. Peter Selin, who holds the position as Executive Vice President Corporate Development and Finance, has more than 20 years of experience in development, licensing and commercialization of specialty pharma products. Peter has previously held senior business development and operational positions, e.g. as Vice President Corporate Development at Sobi and Chief Business Officer at Vivesto.

In his previous roles, Peter has executed a number of licensing transactions and in his new role as CEO he will continue to be responsible for licensing activities and strategic partnerships.